Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
Introduction: Cardiac amyloidosis is the most common cause of infiltrative cardiomyopathy and is associated with a poor prognosis. Transthyretin cardiac amyloidosis, particularly the type caused by the mutation that replaces the amino acid valine with the amino acid isoleucine at position 122 (Val12...
Saved in:
Main Authors: | Gabriela Molina O (Author), Daniel Judge (Author), Wayne Campbell (Author), Harjit Chahal (Author), Marc Mugmon (Author) |
---|---|
Format: | Book |
Published: |
Greater Baltimore Medical Center,
2014-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A review of transthyretin cardiac amyloidosis
by: Jhawar Nikita, et al.
Published: (2023) -
The Structural Understanding of Transthyretin Misfolding and the Inspired Drug Approaches for the Treatment of Heart Failure Associated With Transthyretin Amyloidosis
by: Shan He, et al.
Published: (2021) -
Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis
by: Ilknur Ak Sivrikoz, et al.
Published: (2020) -
Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021) -
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
by: Dulce Brito (Chair), et al.
Published: (2023)